Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Chevron
CVX
|
+$331M |
| 2 |
Walmart
WMT
|
+$229M |
| 3 |
Linde
LIN
|
+$187M |
| 4 |
PayPal
PYPL
|
+$145M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$903M |
| 2 |
Uber
UBER
|
+$565M |
| 3 |
Exxon Mobil
XOM
|
+$450M |
| 4 |
Novo Nordisk
NVO
|
+$393M |
| 5 |
Apple
AAPL
|
+$317M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Healthcare | 17.05% |
| 3 | Consumer Discretionary | 13.22% |
| 4 | Financials | 8.79% |
| 5 | Consumer Staples | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Sealed Air
SEE
$4.97B
| $2.69M | ﹤0.01% |
+72,400
| New | +$2.69M |
|
1827
CytomX Therapeutics
CTMX
$320M
| $2.69M | ﹤0.01% |
1,232,800
-92,900
| -7% | -$203K |
|
1828
Virtus Investment Partners
VRTS
$1.33B
| $2.69M | ﹤0.01% |
+10,829
| New | +$2.69M |
|
1829
Southern First Bancshares
SFST
$367M
| $2.68M | ﹤0.01% |
84,507
+4,000
| +5% | +$127K |
|
1830
Outfront Media
OUT
$3.16B
| $2.67M | ﹤0.01% |
+161,743
| New | +$2.67M |
|
1831
WisdomTree US LargeCap Dividend Fund
DLN
$5.31B
| $2.67M | ﹤0.01% |
37,000
+16,500
| +80% | +$1.19M |
|
1832
Ingevity
NGVT
$2.14B
| $2.66M | ﹤0.01% |
55,800
+42,400
| +316% | +$2.02M |
|
1833
Vera Bradley
VRA
$58.4M
| $2.66M | ﹤0.01% |
391,540
-47,300
| -11% | -$322K |
|
1834
DXP Enterprises
DXPE
$1.88B
| $2.65M | ﹤0.01% |
49,400
+5,200
| +12% | +$279K |
|
|
VERV
1835
DELISTED
Verve Therapeutics
VERV
| $2.65M | ﹤0.01% |
199,327
+34,760
| +21% | +$462K |
|
1836
United Microelectronic
UMC
$17.2B
| $2.64M | ﹤0.01% |
326,200
-2,319,650
| -88% | -$18.8M |
|
1837
Nurix Therapeutics
NRIX
$669M
| $2.64M | ﹤0.01% |
179,300
+64,100
| +56% | +$942K |
|
1838
Evolent Health
EVH
$1.02B
| $2.63M | ﹤0.01% |
+80,199
| New | +$2.63M |
|
1839
Invesco S&P 500 Quality ETF
SPHQ
$15.3B
| $2.63M | ﹤0.01% |
43,500
-40,400
| -48% | -$2.44M |
|
1840
LifeMD
LFMD
$276M
| $2.62M | ﹤0.01% |
255,100
+61,700
| +32% | +$634K |
|
1841
Green Dot
GDOT
$761M
| $2.62M | ﹤0.01% |
280,800
+195,078
| +228% | +$1.82M |
|
1842
AngloGold Ashanti
AU
$33.7B
| $2.62M | ﹤0.01% |
117,916
-575,700
| -83% | -$12.8M |
|
1843
Gambling.com
GAMB
$289M
| $2.62M | ﹤0.01% |
286,800
+58,600
| +26% | +$535K |
|
1844
Movado Group
MOV
$442M
| $2.62M | ﹤0.01% |
93,698
+38,898
| +71% | +$1.09M |
|
|
PMT
1845
PennyMac Mortgage Investment
PMT
$1.07B
| $2.61M | ﹤0.01% |
178,000
+155,808
| +702% | +$2.29M |
|
1846
ALX Oncology
ALXO
$56.2M
| $2.61M | ﹤0.01% |
234,100
-36,400
| -13% | -$406K |
|
|
GMRE
1847
Global Medical REIT
GMRE
$512M
| $2.61M | ﹤0.01% |
298,100
+146,200
| +96% | +$1.28M |
|
1848
Immersion
IMMR
$227M
| $2.6M | ﹤0.01% |
347,700
-55,500
| -14% | -$415K |
|
1849
Air T
AIRT
$69.2M
| $2.6M | ﹤0.01% |
116,911
-1,100
| -0.9% | -$24.4K |
|
1850
Equitable Holdings
EQH
$16.1B
| $2.59M | ﹤0.01% |
+68,200
| New | +$2.59M |
|